Endothelial progenitor cells bind and inhibit platelet function and thrombus formation

Haissam Abou-Saleh, Daniel Yacoub, Jean François Théorêt, Marc Antoine Gillis, Paul Eduard Neagoe, Benoit Labarthe, Pierre Théroux, Martin G. Sirois, Maryam Tabrizian, Eric Thorin, Yahye Merhi

Research output: Contribution to journalArticle

60 Citations (Scopus)


BACKGROUND- Interactions of endothelial progenitor cells (EPCs) with vascular and blood cells contribute to vascular homeostasis. Although platelets promote the homing of EPCs to sites of vascular injury and their differentiation into endothelial cells, the functional consequences of such interactions on platelets remain unknown. Herein, we addressed the interactions between EPCs and platelets and their impact on platelet function and thrombus formation. METHODS AND RESULTS: Cultured on fibronectin in conditioned media, human peripheral blood mononuclear cells differentiated, within 10 days of culture, into EPCs, which uptake acetylated low-density lipoprotein, bind ulex-lectin, lack monocyte/leukocyte markers (CD14, P-selectin glycoprotein ligand-1, L-selectin), express progenitor/endothelial markers (CD34, vascular endothelial growth factor receptor-2, von Willebrand factor, and vascular endothelial cadherin), and proliferate in culture. These EPCs bound activated platelets via CD62P and inhibited its translocation, glycoprotein IIb/IIIa activation, aggregation, and adhesion to collagen, mainly via prostacyclin secretion. Indeed, this was associated with upregulation of cyclooxygenase-2 and inducible nitric oxide synthase. However, the effects on platelets in vitro were reversed by cyclooxygenase and cyclooxygenase-2 inhibition but not by nitric oxide or inducible nitric oxide synthase inhibition. Moreover, in a ferric chloride-induced murine arterial thrombosis model, injection of EPCs led to their incorporation into sites of injury and impaired thrombus formation, leading to an incomplete occlusion with 50% residual flow. CONCLUSIONS: Peripheral blood mononuclear cell-derived EPCs bind platelets via CD62P and inhibit platelet activation, aggregation, adhesion to collagen, and thrombus formation, predominantly via upregulation of cyclooxygenase-2 and secretion of prostacyclin. These findings add new insights into the biology of EPCs and define their potential roles in regulating platelet function and thrombosis.

Original languageEnglish
Pages (from-to)2230-2239
Number of pages10
Issue number22
Publication statusPublished - Dec 2009
Externally publishedYes



  • Nitric oxide
  • Platelets
  • Progenitor cells
  • Prostaglandins
  • Thrombosis

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Abou-Saleh, H., Yacoub, D., Théorêt, J. F., Gillis, M. A., Neagoe, P. E., Labarthe, B., Théroux, P., Sirois, M. G., Tabrizian, M., Thorin, E., & Merhi, Y. (2009). Endothelial progenitor cells bind and inhibit platelet function and thrombus formation. Circulation, 120(22), 2230-2239. https://doi.org/10.1161/CIRCULATIONAHA.109.894642